← All trials
NCT00132561
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2002
- Primary completion
- —
- Completion date
- Dec 1, 2003
- First posted
- —
- Last posted
- —
- Enrollment
- 1200
- Arms / groups
- — / —
- Source
- AACT · pre-existing
Sponsors
- University of LondonLead sponsor
- Government of FranceOverall official - principal investigator
- Cheikh Anta Diop University, SenegalCollaborator
- University of LondonReponsible party - principal investigator
- Government of SenegalCollaborator
- Government of FranceCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.